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The identification and molecular characterization of cellular hierarchies in complex tissues is key to 13 
understanding both normal cellular homoeostasis and tumorigenesis. The mammary epithelium is a 14 
heterogeneous tissue consisting of two main cellular compartments, an outer basal layer containing 15 
myoepithelial cells and an inner luminal layer consisting of estrogen receptor negative (ER-) ductal cells 16 
and secretory alveolar cells (in the fully functional differentiated tissue) and hormone responsive estrogen 17 
receptor positive (ER+) cells. Recent publications have used single cell RNA-sequencing (scRNA-seq) 18 
analysis to decipher epithelial cell differentiation hierarchies in human1 and murine2–4 mammary glands and 19 
reported the identification of new cell types and states based on the expression of the luminal progenitor cell 20 
marker KIT (c-Kit)1,2. These studies allow for comprehensive and unbiased analysis of the different cell 21 
types that constitute a heterogeneous tissue. Here we discuss scRNA-seq studies in the context of previous 22 
research in which mammary epithelial cell populations were molecularly and functionally characterized, 23 
and identified c-Kit+ progenitors and cell states5 analogous to those reported in the recent scRNA-seq 24 
studies.  25 
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 26 
Previous studies to elucidate the cellular identities of mammary epithelial subpopulations have involved 27 
functional and molecular characterization by flow cytometric and functional (down to single cell) 28 
transplantation assays6–19 as well as, more recently, lineage tracing studies20–31. Transplantation experiments 29 
have generally supported a model in which facultative MaSCs,  cells capable of regenerating the epithelium 30 
when injected into a cleared mammary fat pad (one free of endogenous epithelium)6,32, are localized to the 31 
basal cell layer5,10,14,33–35. Progenitor cells, which are functionally defined by high colony forming and 32 
proliferative potential in vitro and limited repopulating ability when transplanted into cleared fat pads, are 33 
localized to the luminal layer5,11,15,34. Differentiated cells do not transplant or generate colonies in vitro. The 34 
molecular profiling of mammary epithelial subpopulations functionally defined by their transplantation 35 
potential has been extensive14,22,36–45.  36 
 37 
Supporting this model, in situ evidence, including lineage tracing studies from early mammary 38 
development, puberty and alveolargenesis during pregnancy have shown that basal cells can contribute 39 
to the luminal layer24,46–48. We previously proposed, based on in situ analysis, that basal MaSCs located 40 
in the cap cell layer of terminal end buds (TEBS), the outermost cell layer of the specialized growth 41 
structure that drives ductal growth during puberty, are bipotent and produce daughter cells that contribute 42 
to both the basal and luminal cell lineages48. Lineage tracing experiments from Rios et al. (2014) and 43 
Wang et al. (2014) were in agreement with transplantation data and our in situ analysis suggesting that 44 
MaSCs in the developing postnatal gland are bipotent20,21,48. However, more recently it has been shown that, 45 
rather than a transcriptionally defined bipotent TEB MaSC, a group of transcriptionally heterogeneous 46 
lineage committed MaSCs mediate development of the pubertal mammary gland and contribute transiently 47 
to ductal expansion28, mirroring the organization and neutral drift of adult stem cells observed in the 48 
intestine49,50. This model of postnatal mammary gland development is in agreement with saturation, single-49 
cell genetic and neutral lineage-tracing studies demonstrating that bipotent fetal MaSCs (fMaSCs), first 50 
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functionally and molecularly characterized (including single cell gene expression analysis demonstrating 51 
molecular heterogeneity) by Spike et al. (2012)42, exist in the embryo but that in the postnatal gland, 52 
basal and luminal lineages are maintained by separate lineage committed stem/progenitor populations23–53 
29,47,51–53. During oncogenic transformation basal and luminal cell populations may lose this restricted 54 
lineage potential and acquire multipotency25,29,54,55. 55 
 56 
Recent studies have used scRNA-seq, which unlike functional and population based sequencing studies, 57 
allows for unbiased analysis of individual cells in a heterogeneous tissue, to decipher lineage hierarchies 58 
and cell states in the mammary epithelium1–4. To investigate cellular heterogeneity and lineage relationships 59 
in the human breast, Nguyen et al. (2018) performed scRNA-seq analysis on fluorescence-activated cell 60 
sorted (FACS) breast epithelial cells and reported the identification of additional cell types within the 61 
three main mammary epithelial cell populations, previously identified as basal (B: CD49fHigh EPCAM+, 62 
K14+), luminal progenitors (L1: CD49f+ EPCAM+, ER-, K8/18+), and mature luminal (L2: CD49f− 63 
EPCAM+, ER+, K8/18+) cells1,13,15. Significantly, the authors detected replicating KIT+ cells in all three 64 
main populations (Basal, L1, and L2), suggesting that each cluster may be maintained by its own KIT+ 65 
progenitor cell population and proposed a continuous lineage hierarchy connecting the basal lineage to  66 
the two luminal branches via a bipotent MaSC. Furthermore, the authors highlight adult luminal cells 67 
that co-express both luminal (KRT8/18) and basal (KRT14) markers in situ.  68 
 69 
The receptor tyrosine kinase KIT (c-Kit) has previously been identified as a defining marker of mammary 70 
epithelial progenitor cells (summarized in Table 1) and of the cells of origin of BRCA1-mutation breast 71 
cancer, luminal ER- cells5,22,39,45,55,56. Similar to Nguyen et al. (2018), in Regan et al. (2012) we identified 72 
in the mouse, and also functionally tested via in vitro colony forming assays and cleared mammary fat pad 73 
transplantation, c-Kit- and c-Kit+ cell states within each of the mammary epithelial basal (CD24+/Low Sca-1- 74 
CD49f+/High c-Kit- and c-Kit+), myoepithelial (CD24+/Low Sca-1- CD49f+/Low c-Kit- and c-kit+), luminal ER- 75 
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(CD24+/High Sca-1- c-Kit+/Low and c-Kit+/High) and luminal ER+ (CD24+/Low Sca-1- c-Kit-, CD24+/Low Sca-1+ 76 
c-kit- and c-kit+) cellular compartments5. The expression of KIT, as well as the luminal markers KRT8/18 77 
and ESR1 and basal marker KRT14, in each of Nguyen et al.’s human breast populations of B, Myo, L1.1, 78 
L1.2 and L2 are consistent with the expression levels reported in Regan et al. (2012) in the corresponding 79 
murine basal, myoepithelial, luminal ER- c-Kit+/High, luminal ER- c-Kit+/Low, and luminal ER+ cells, 80 
respectively (Figure 1). The KIT+ cells identified by Nguyen et al. (2018) are therefore likely equivalent 81 
to the c-Kit+ progenitor cells previously reported in Regan et al. (2012), which was the first study to 82 
functionally characterize c-Kit as a progenitor marker in the mammary gland (Table 1). When discussing 83 
KIT as a progenitor cell marker, Nguyen et al. incorrectly cites Stingl et al. (2001)57 and Shehata et al. 84 
(2012)15. These papers, respectively, did not investigate or functionally test c-Kit as a progenitor marker 85 
in the mammary gland. 86 
 87 
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 88 
Study (year) Method(s) Cells / Progenitor cell markers Results
Natali et al. (1992)
Matsuda et al. (1993)
Hines et al. (1995)
Ulivi et al. (2004)
Tsuda et al. (2005)
Westbury et al. (2009)
Immunohistochemistry Normal human breast tissue High levels of c-Kit protein detected in the
luminal alveolar/ductal epithelium but not in
basal/myoepithelial layer.
Shackleton et al. (2006)
Stingl et al. (2006) 
Sleeman et al. (2006) 
Sleeman et al. (2007) 
Asselin-Labat et al. (2007) 
FACS
Colony-forming assays
Gland reconstitution
Immunostaining 
Gene expression analysis 
Mouse mammary cell populations
Basal CD24
+/Low 
Sca1
-
CD49f/CD29
+/High
Luminal ER
-
CD24
+/High 
Sca1
-
/CD61
+
Luminal ER
-
cells are in vitro progenitors and
possess limited mammary gland repopulation
potential.
Basal cells contain facultative MaSCs.
Kendrick et al. (2008) Transcriptome analysis Mouse mammary cell populations
Basal CD24
+/Low
Sca-1
-
Luminal ER
−
CD24
+/High
Sca-1
-
Luminal ER
−
CD24
+/High
Sca-1
-
progenitor cells
are enriched for c-Kit expression.
Lim et al. (2009)
Lim et al. (2010)
FACS
Colony-forming assays
Gland reconstitution
Immunostaining 
Transcriptome analysis
Mouse mammary cell populations
Basal CD29
hi
CD24
lo
CD61
+
Luminal ER
-
CD29
lo
CD24
+
CD61
+
Human mammary cell populations
Basal CD49f
+/hi
EpCAM
+/lo
Luminal ER
-
CD49f
+
EpCAM
+/hi
c-Kit is highly expressed in mouse and human
luminal progenitor cells. Functional testing of
isolated c-Kit
+
cells was not carried out in these
studies.
Regan et al. (2012)
[Epub 18 July 2011]
FACS
Colony-forming assays
Gland reconstitution
Immunostaining
Gene expression analysis
Mouse mammary cell subpopulations
Basal CD24
+/Low
Sca-1
-
CD49f
+/High
c-Kit
-
Basal CD24
+/Low
Sca-1
-
CD49f
+/High
c-Kit
+
Luminal ER
-
CD24
+/High
Sca-1
-
c-Kit
+/Low
Luminal ER
-
CD24
+/High
Sca-1
-
c-Kit
+/High
Luminal ER
+
CD24
+/High
Sca-1
+
c-kit
+
c-Kit is an in vitro and in vivo functional marker
of mammary progenitors and lineage primed cell
states in basal, luminal ER
-
and luminal ER
+
cell
populations.
Facultative MaSCs are CD24
+/Low
Sca-1
-
CD49f
+/High
c-Kit
-
.
Asselin-Labat et al. (2011)
[Epub 19 Sept. 2011]
FACS
Colony-forming assays
Gland reconstitution
Immunostaining
Gene expression analysis
Mouse mammary cell subpopulations
Luminal ER
-
CD29
lo
CD24
+
CD14
+
c-kit
−/lo
Luminal ER
-
CD29
lo
CD24
+
CD14
+
c-kit
+
c-Kit
+
luminal cells expand during early
pregnancy and are in vitro colony forming
progenitors. In vivo functional testing of isolated
c-Kit
+
cells was not carried out.
Shehata et al. (2012) FACS
Colony-forming assays
Gland reconstitution
Immunostaining
Gene expression analysis
Mouse mammary cell subpopulations
Luminal ER
-
EpCAM
+
Sca-1
-
CD49b
+
CD14
+
Luminal ER
+
EpCAM
+
Sca-1
+
CD49b
+
CD14
+
Human mammary cell subpopulations
Luminal CD49f
+
EpCAM
+/hi
ALDH
+
ERBB3
+
Luminal CD49f
+
EpCAM
+/hi
ALDH
-
ERBB3
+
Luminal CD49f
+
EpCAM
+/hi
ALDH
-
ERBB3
-
Identified luminal ER
-
and luminal ER
+
progenitor cells in mouse and human.
Detected c-Kit
+
cells in the luminal populations
of FVB/N mice but not in C57Bl6/J mice.
Functional testing of isolated c-Kit
+
cells was not
carried out in this study.
Pal et al. (2017) scRNA-Seq Mouse mammary cell populations
Basal CD29
hi
CD24
+
Luminal CD29
lo
CD24
+
Hierarchical clustering revealed luminal
progenitors are enriched for c-Kit. Transcriptome
mapping identified rare c-Kit
+
lineage primed
basal cells.
Bach et al. (2017) scRNA-seq Nulliparous, embryonic, lactating and
post-involution mouse mammary cells
EpCAM
+
Identified c-Kit
+
luminal progenitor cells that
give rise to intermediate, alveolar and hormone-
sensitive progenitors.
Kim & Villadsen. (2018) Immunohistochemistry Normal human breast tissue
EpCAM
+
Ki-67
+
KIT
+
KIT
+
cells constitute a proliferating (Ki-67
+
)
luminal progenitor compartment during
homeostasis of the resting gland.
Nguyen et al. (2018) scRNA-seq Human mammary cell populations
Basal (B) CD49f
High
EPCAM
+
Luminal (L1) ER
-
CD49f
+
EPCAM
+
Luminal (L2) ER
+
CD49f
−
EPCAM
+
Identified KIT
+
progenitor cells in each
mammary population, including L1.1 luminal
(ER
-
KIT
+/High
) and L1.2 luminal (ER
-
KIT
+/Low
)
progenitors.
Giraddi et al. (2018)
Chung et al. (2019)
scRNA-seq
snATAC-seq
Embryonic and post-natal mouse
mammary cells
EpCAM
+
c-Kit is most highly expressed and chromatin
accessible in luminal progenitor cells.
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Table 1: Studies demonstrating that luminal ER- cells are enriched for c-Kit and that c-Kit identifies 89 
progenitor cells in the mammary epithelium1–5,10,11,14,15,22,34,39,45,56,58–66. 90 
 91 
 92 
Figure 1: Comparison of gene expression in cell populations identified by Nguyen et al. (2018) and 93 
Regan et al. (2012). Nguyen et al. (2018) violin plots showing the expression pattern of progenitor 94 
marker KIT (a; LHS), luminal genes ESR1 and KRT8 (b – c; LHS) and basal gene KRT14 (d; LHS) 95 
grouped by final cluster determination in human mammary epithelium. B = Basal (containing facultative 96 
MaSCs), Myo = Myoepithelial. Regan et al. (2012) gene expression in the different cellular 97 
subpopulations as determined by qPCR relative to comparator (luminal Sca-1+ c-Kit+ cells) for progenitor 98 
gene c-Kit (a; RHS), luminal genes Esr1 and Krt18 (b – c; RHS) and basal gene Krt14 (d; RHS) in murine 99 
mammary epithelium. Data are presented as fold expression levels ±95% confidence intervals (n=three 100 
independently harvested isolates of each cell population). *Gene expression was undetectable in these 101 
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populations in all three independent isolates. **Gene expression was only detected (at very low levels) 102 
in two of three isolates of the luminal Sca-1+ c-Kit− population. Therefore, no error bars are shown for 103 
this sample. Violin plots used with permission under a CC-BY 4.0 license from Nguyen et al. (2018)1. 104 
 105 
Nguyen et al. (2018) observed fractions of cells that co-express both luminal K8 and basal K14 markers 106 
and report that such K8+ K14+ cells had previously been observed in mouse fMASCs by Spike et al. 107 
(2012)42 (such fetal cells were also previously described by Sun et al. (2010)67), but not in adult human 108 
tissue in homeostasis. However, while the canonical view amongst mouse mammary developmental 109 
biologists is that the K5/14 pair is a basal marker and the K8/18 pair is a luminal marker68–70, breast 110 
pathologists have known for many years that keratins 5 and 14 (and indeed another ‘basal’ keratin, 17) 111 
are in fact expressed in basal cells of human breast ducts and in the luminal cells of the terminal ductal 112 
lobuloalveolar units (TDLUs)68,71–74. Indeed, K5/K18 and K14/K18 double positive cells are not 113 
uncommon in human TDLUs71. More recently, Boecker et al. (2018), identified K5+ K18/19- and K5+ 114 
K18/K19+ populations in the luminal layer of ductal and TDLU breast tissue in situ75, while in human 115 
breast epithelial populations isolated by flow cytometry, the progenitor populations (Lin− CD49f+ 116 
EpCAMhi) include cells double positive for K5/6 and K14 – and notably are also c-KIT+45. To add to the 117 
complexity of these marker patterns, K19 has been described both as a marker of progenitors76–78 and 118 
highly expressed in differentiated luminal ER+ cells11,79. 119 
 120 
Boecker et al. (2018) termed the populations they identified as progenitors and intermediary cells, 121 
respectively, but it is difficult to definitively assign such functions purely on the basis of marker 122 
expression, or indeed ex vivo assays. Of course, human breast tissue cannot be lineage traced through 123 
transgene activation as one can in the mouse but use of cytochrome C oxidase (CCO) mutations in the 124 
mitochondrial genome has proven feasible as an approach. Cereser et al. (2018) report the presence of 125 
CCO-deficient clonal expansions in both ducts and TDLUs of normal breast80. Notably, the expansions 126 
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were limited to the luminal layers and they found no evidence of luminal CCO-deficient clones 127 
contributing to the basal layer. Therefore, if the K5/K14/c-KIT+ luminal cells of the human breast are 128 
indeed progenitors, they are lineage restricted. 129 
 130 
Keratin expression patterns in the mouse mammary epithelium are somewhat easier to define, but also 131 
not as straightforward as often suggested. Unlike in the human, when analyzed in situ, K14 and K8/18 in 132 
the mouse appear to be restricted to the basal and luminal cell layers, respectively. Indeed, we have rarely 133 
(if ever) observed a luminal cell in the normal resting adult mammary gland we could confidently say is 134 
K14 positive, or a basal cell which is K8/18 positive, by immunofluorescence in situ, and this is in 135 
agreement with most studies. However, immunohistochemical analysis of the mouse mammary gland by 136 
Mikaelian et al. (2006) has detected rare weak K14 staining of luminal cells from birth to puberty and 137 
weak K8/18 labelling of basal cells during mammary morphogenesis, which were most easily visualized 138 
during lactation69. As an added complication, it should be noted that in the mammary alveoli, the 139 
basal/myoepithelial cells form a classic ‘basket-like network’ around the secretory cells, and in that 140 
location the ‘luminal’ cells are in fact touching the basement membrane through the gaps between the 141 
myoepithelial cells. Interestingly, therefore, in agreement with Mikaelian et al. (2006), when basal and 142 
luminal sub-populations were isolated by flow cytometry and stained by immunofluorescence, we found 143 
that c-Kit+ luminal cells (which were approx. 50% of the total mammary epithelium) were all strongly 144 
K18+ but also weakly K14+ and that c-Kit+ basal cells were strongly K14+ and weakly K18+ (Figure 2b)5. 145 
c-Kit negative single luminal and basal cells prepared and stained at the same time were respectively 146 
K18+ K14- and K14+ K18-, suggesting we were not seeing background staining in the c-Kit positive cells. 147 
This discrepancy is likely due to signal/noise ratio when using in situ immunofluorescence approaches – 148 
enhancing the K14 staining to a level where it can be detected in luminal cells would result in a huge 149 
excess of staining from the basal cells as well as background signal from other cell types in the mammary 150 
gland (and likewise for K18 detection in basal cells), which is notorious for background fluorescence 151 
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coming from adipocytes. Thus, only approaches based on single cell separation will accurately detect 152 
mouse cells expressing the ‘luminal’ keratin 18 and the ‘basal’ keratin 14, and as we report using such 153 
approaches, such cells express the c-Kit marker5. Note that the scRNA-seq analysis of mouse mammary 154 
epithelium by Bach et al. (2017) shows that a subset of luminal cells have Krt14 expression levels 155 
equivalent to the mean expression level of Krt14 in basal cells. Their differentiation trajectory maps show 156 
that the Krt14 expressing luminal cells are enriched in a progenitor population which is also c-Kit-157 
positive3 158 
 159 
In contrast, we find cells double positive for ‘basal’ keratin 5 and ‘luminal’ keratin 19 are readily 160 
detectable in the mouse luminal epithelium in situ (Figure 2 c-d). Interestingly, K19 has been proposed 161 
to be a neutral switch keratin that permits the changeover of one type of cytoskeleton to the other78,81. 162 
We have particularly noted K5 positive cells in the body cell region of terminal end buds in situ (Figure 163 
2c). The origin of these cells is unclear. Rios et al. (2014) reported that using a Krt5-promoter driven cell 164 
labelling approach, labelled cells were only observed in the basal compartment but generated both 165 
luminal and basal daughter clones, and hence proposed the existence of bipotent basal stem cells arising 166 
from the basal layer of the TEBs21. However, the work of Scheele et al. (2018)28 and others23–28,51,52 167 
suggests that cap cells (the basal cell layer of the TEBs) do not contribute to the luminal layer of the 168 
subtending duct, therefore K5 positive body cells, if they are cap cell derived, are unlikely to contribute 169 
to outgrowth of the ducts. In contrast, if these cells are derived from the body cells, they are switching 170 
on high levels of K5 expression, but whether this is only transient – perhaps a temporary failure of lineage 171 
specification in a newly established daughter cell which is later corrected – is unclear. 172 
 173 
Therefore, while use of keratins as basal/luminal lineage markers is more robust in the mouse mammary 174 
epithelium than in the human, single cell analysis approaches have demonstrated that even the mouse has 175 
a more promiscuous pattern of keratin expression than previously suspected, and that this promiscuous 176 
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expression of keratins is seen in c-KIT+ stem/progenitor cells. Plasticity in the expression of keratins and 177 
other genes within c-Kit+ luminal progenitors may relate to their potential to contribute to multiple cell 178 
lineages during epithelial remodeling, e.g. at involution of the mammary gland after weaning82. In 179 
addition, the phenotypic plasticity and multilineage differentiation potential of these luminal progenitors 180 
is consistent with their ability to give rise to tumors with basal features45,55 as well as lineage switching 181 
in response to injury and oncogene activation25,29,54. It is clear, therefore, that a great deal of caution must 182 
be used when keratin promoters are being used for lineage tracing studies in the mouse or for assigning 183 
luminal/basal identity in human cells. Indeed, in a dissociated human breast epithelial cell population, 184 
keratin expression levels alone cannot be used to assign basal/luminal identity to a cell with any 185 
confidence. 186 
 187 
 188 
 189 
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Figure 2. Basal and luminal marker expression suggests potential for differentiative plasticity in 191 
the mouse mammary gland in situ. (a) Immunofluorescence of sections though the mammary fat pads 192 
of adult virgin female FVB mice stained with antibodies against the luminal markers K18 and c-Kit and 193 
the basal marker K14. c-Kit staining is located predominantly in the K18+ K14- luminal layer, although 194 
occasional K14+ c-Kit+ basal cells are detected (arrowhead). Bar = 40 µm. (b) K18 and K14 staining of 195 
freshly isolated single c-Kit+ luminal and c-Kit+ basal cells from adult virgin mice sorted directly onto 196 
slides. Insets show c-Kit- luminal and basal cells negative for K14 (LHS) and K18 (RHS), respectively. 197 
(Bar = 3 µm). The numbers of cells examined and overall staining patterns are given in Table 1 of Regan 198 
et al. 20125. (c) Basal K5 staining in the terminal end buds (TEBs) and subtending duct of four-week-199 
old pubertal mouse mammary epithelium. K5 staining is located predominantly in the basal layer. 200 
Occasional K5+ cells are detected in the luminal layer (arrowheads). Bar = 40 μm. (d) Section through a 201 
cleared fat pad outgrowth double stained for basal K5 and luminal K19. A K5+ K19+ double positive cell 202 
is observed in the basal layer (arrowhead). Bar = 40µm. All cells were counterstained with DAPI (blue). 203 
 204 
To address the debate as to whether homeostasis and development in the postnatal mammary gland is 205 
maintained by bipotent MaSCs20,21,48 or lineage-restricted basal and luminal cells4,24–27, Nguyen et al. 206 
(2018) performed pseudotemporal reconstruction-based lineage hierarchy analysis. This analysis 207 
identified a continuous lineage connecting the basal lineage, via a bipotent MaSC, to the two luminal 208 
branches. These results agree with previous models of mammary differentiation wherein a bipotent basal 209 
MaSC generates daughter cells that differentiate into myoepithelial and luminal cell lineages20,21,48. 210 
However, Nguyen et al. propose that their results differ from previous studies in that L1.2 cells (luminal 211 
ER- c-kit+/Low cells) are progenitors to L1.1 cells (luminal ER- c-Kit+/High cells) and that c-Kit+/High L1.1 212 
cells are another type of mature differentiated luminal cell rather than a luminal progenitor upstream of 213 
luminal ER+ L2 cells. Based on this pseudotemporal analysis the authors suggest that KIT is not a marker 214 
of luminal progenitor cells. This is a surprising conclusion considering that L1.2 progenitor cells do 215 
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express KIT (Figure 1), which as well as being a defining marker of mouse and human progenitor cell gene 216 
expression signatures2–4,22,39,45,65, has been functionally demonstrated as a progenitor cell marker5 (Table 1).  217 
 218 
Similar to Nguyen et al. (2018), Pal et al. (2017) used scRNA-seq to identify lineage relationships in the 219 
mouse mammary gland and also suggested that bipotent basal MaSCs give rise to basal and luminal 220 
lineages2. Supporting our previous assessment of intermediate cells in the luminal lineage5, the authors 221 
also described the identification of intermediate luminal cells. Significantly, Pal et al. report the 222 
identification of rare mixed-lineage or “lineage-primed” c-Kit-expressing basal cells in the adult 223 
mammary gland and state, “It is presumed that these cells represent a transient population that is poised 224 
for commitment to the luminal lineage, reminiscent of ‘lineage-primed’ stem and progenitor cells initially 225 
reported in the hematopoietic system.” These lineage-primed c-Kit+ basal cells comprised approximately 226 
5% of the basal compartment and expressed luminal genes such as Esr1, Prlr, Csn2 and Areg in addition 227 
to basal genes. Pal et al. state, “these data suggest that the basal state may precede commitment to a 228 
luminal cell fate in the post-natal mammary gland.”  229 
 230 
In Regan et al. (2012) we also identified cells that we described as lineage-primed basal cells (CD24+/Low 231 
Sca-1- CD49f+/High c-Kit+) in the adult mammary gland that expressed luminal genes, including those 232 
described by Pal et al. (Esr1, Prlr, Csn2, Areg), but that clustered with the basal facultative MaSCs5. 233 
Significantly, we functionally tested these cells by single cell cleared mammary fat pad transplantation 234 
and demonstrated that they can reconstitute an entire ductal tree, although at a lower frequency (1 in 8 ± 235 
95% CI 1 in 3 – 1 in 21.3) than facultative c-Kit- MaSCs (1 in 3 ± 95% CI 1 in 1.69 – 1 in 6.27), the 236 
highest enrichment of facultative MaSCs reported to date and potentially a pure facultative MaSC 237 
population. Based on these data we came to the same conclusion as Pal et al. (2017) and described these 238 
c-Kit+ basal cells as intermediate MaSCs that were undergoing “lineage priming”, in which stem cells 239 
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express genes associated with their differentiated daughter populations83,84. This was the first time that 240 
lineage-primed basal cells in the adult mammary gland had been reported and functionally tested.  241 
 242 
In contrast to Nguyen et al. (2018) and Pal et al. (2017), scRNA-Seq by Bach et al. (2017)3 on mouse 243 
mammary epithelial cells at nulliparous, mid gestation, lactation and post involution concluded that, 244 
rather than clearly defined clusters maintained by their own stem/progenitor population, a continuous 245 
spectrum of differentiation exists. In this model, a common luminal progenitor cell, which notably 246 
expressed c-Kit at high levels, gives rise to intermediate, restricted alveolar, and hormone-sensitive 247 
progenitors.  248 
 249 
More recently, Giraddi et al. (2018) used scRNA-seq and transposase-accessible chromatin sequencing 250 
(ATAC-seq), which examines global chromatin accessibility85, of embryonic, postnatal and adult mouse 251 
mammary epithelia, to elucidate the lineage hierarchies and biological programs that generate mature 252 
cell types from their embryonic precursors4. This work was more consistent with the conclusions of Bach 253 
et al. (2017) than Nguyen et al. (2018) and Pal et al. (2017), as well as the lineage tracing studies showing 254 
that while embryonic mammary cells are bipotent, in the adult gland, basal and luminal cell lineages are 255 
derived from and maintained by separate lineage committed progenitor populations23–29,47,51–53.  256 
 257 
Similar to Pal et al. (2017), Giraddi et al. (2018) also identified rare c-Kit+ basal cells, although they did 258 
not occur at a frequency greater than the expected doublet frequency (1%) of the 10X Genomics 259 
Chromium System sequencing platform4; a frequency similar to the c-Kit+ basal cells that Pal et al. 260 
(2017) also detected using the 10X platform. In contrast, the lineage primed c-Kit+ basal cells that we 261 
identified in our 2012 study were visually confirmed to be single cells prior to performing the single cell 262 
transplants, in which they displayed a transplantation frequency intermediary to facultative c-Kit- MaSCs 263 
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and c-Kit+ luminal progenitor cells. In addition, immunofluorescence staining of single c-Kit+ basal cells 264 
demonstrated that they expressed both K14 and K18 (Figure 2B)5. 265 
 266 
Transcriptional profiling by Giraddi et al. (2018) did not detect any distinct adult basal stem cell 267 
subpopulation. However, ATAC-seq revealed that adult basal cells display an embryonic MaSC-type 268 
chromatin accessibility at luminal gene loci, which the authors speculate allows for lineage 269 
plasticity4,65,86. Such plasticity may account for acquisition of multilineage potential upon perturbation 270 
of a homeostatic niche environment, such as during cell isolation and ex vivo culture, transplantation 271 
assays, wounding and cancer4,54,86–89. The performance of a particular cell type during functional assays 272 
may therefore be a product of both their transcriptional heterogeneity and the context in which they are 273 
challenged54. Similar functional stem cell capacities have also been described in embryonic tissue, 274 
intestine, bone marrow, skin and lung90–92. These observations challenge the concept of fixed cell 275 
identities in complex tissues and suggest a more fluid concept of cell state (for a more detailed discussion 276 
of this concept see Wahl & Spike (2017))54. With this in mind, a potential mammary epithelial cell 277 
hierarchy based on lineage tracing, functional analyses and recent scRNA-seq and snATAC-seq studies is 278 
shown in Figure 3. 279 
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 280 
Figure 3: Proposed model (adapted with permission from Giraddi et al., 2018)4 of the mammary 281 
epithelial cell state lineage hierarchy in the postnatal gland based on lineage tracing, functional assays, 282 
scRNA-seq and snATAC-seq.  Bipotent fetal mammary stem cells (fMaSCs) are present in the embryo and 283 
become lineage restricted after birth. In the adult gland each lineage is maintained by its own c-Kit+ 284 
progenitor. Loss of homeostasis (e.g. injury, cell isolation, ex vivo culture, transplantation) or tumorigenesis 285 
may trigger a wound response that leads to acquisition of multi-lineage potential by facultative inducible 286 
MaSCs (iMaSCs), c-Kit+ lineage-primed and progenitor cell states. Lineage-primed c-Kit+ basal cells that 287 
express intermediate levels of luminal genes may represent a transient or intermediate population that 288 
precedes commitment to the luminal lineage2,5. Gene expression analysis suggests that an alternative route 289 
for generating ER+ cells from intermediate luminal cell states may also exist.  290 
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Future studies that aim to map fluid cell state dynamics and their regulatory mechanisms will require the 292 
use of single-cell and single-molecule epigenomic technologies that reveal a cells regulatory potential, 293 
rather than its current state, as indicated by its transcriptome93,94. Indeed, Chung et al. (2019) recently 294 
demonstrated that single-cell chromatin accessibility mapping of mammary gland development using 295 
single-nucleus ATAC-seq (snATAC-seq) enables greater resolution of cell state heterogeneity and to be 296 
a better indicator of cell state during development than scRNA-seq65. The lineage relationships delineated 297 
in this study were consistent with those of Bach et al. (2017) and Giraddi et al. (2018) and also found c-298 
Kit to be most highly expressed and chromatin accessible in luminal progenitor cells.  299 
 300 
Concluding Remarks 301 
Taken together, the weight of evidence supports c-Kit as a progenitor marker in the mammary 302 
epithelium and, more importantly, one which is functionally characterized and can be used to enrich 303 
stem/progenitor cells. Indeed, we have already begun to understand the signaling pathways 304 
downstream of c-Kit in mammary progenitor cells95. scRNA-seq studies, which allow for 305 
comprehensive and unbiased analysis of the different cell types that constitute a heterogeneous 306 
tissue96, have been extremely valuable in contributing to our understanding of lineage relationships 307 
and cell state heterogeneity in the mammary gland. However, in order to fully understand the 308 
significance of these studies it is essential to link them to functional data, in particular where such 309 
data already exists, and future studies should aim to do so. The weight of evidence from lineage 310 
tracing, scRNA-seq and snATAC-seq studies currently supports a model in which fMaSCs in the 311 
embryo are bipotent, whereas in the adult gland, stem/progenitor cells are lineage restricted and 312 
facultative MaSCs (defined by functional studies) are induced to acquire multi-lineage potential upon 313 
loss of homeostasis/injury. Bipotent fetal MaSCs are described as fMaSCs to differentiate them from 314 
adult facultative MaSCs. However, the scientific literature up to now continues to refer to adult cells 315 
with facultative stem cell potential simply as MaSCs or, in a handful of publications, adult MaSCs 316 
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(aMaSCs)42,54, which is no longer an accurate or apt description. We therefore propose the renaming 317 
of MaSCs in the postnatal gland as “inducible mammary stem cells” (iMaSCs). This new definition 318 
will help to more clearly define the status and stem cell potential of functionally defined iMaSCs in 319 
the era of large-scale single-cell molecular profiling. 320 
 321 
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